A phase II randomized placebo-controlled study of fisetin to improve physical function in breast cancer survivors: the TROFFi study rationale and trial design
Related Posts
Lee DR, Matsuno LK, Seo JH, Wong BY, Cook EA, Chen GI, Newbrey K, Stich S, Reuben DB. Keeping Patients on Their Feet: How Fall[...]
Prusynski RA, Humbert A, Amaravadi H, Burke RE, Saliba D, Leland NE, Freburger J, Mroz TM. The role of declining therapy volumes in skilled nursing[...]
Saliba D, Mor V, Hilliard KA, Mochel AL, Baumann M, Boxer R, D'Adamo H, Gotanda H, House KW, Joshi S, Sohn L, Tayade A, Tubbesing[...]